Biotechnology
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

$34.1M

Market Cap • 4/2/2025

2021

(4 years)

Founded

2024

(1 year ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Houston

Headquarters • Texas